PharmAthene, Inc. (PIP) Tops Q3 EPS by 8c; Appoints Linda Chang as CFO
Tweet
Share
E-mailGet Alerts PIP Hot Sheet
Price: $0.65 --0%
Financial Fact:
Total other income (expenses): 113.24M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other income (expenses): 113.24M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
PharmAthene, Inc. (NYSE: PIP) reported Q3 EPS of $0.00, $0.08 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $6.53 million.
The company also announced that Linda L. Chang has joined the Company as Senior Vice President, Chief Financial Officer, effective November 7, 2011. Ms. Chang is responsible for Accounting, Finance, Information Technology, and Investor Relations functions at PharmAthene.
Prior to joining PharmAthene, Ms. Chang spent 11 years at Human Genome Sciences, Inc., (Nasdaq: HGSI) most recently as Senior Director of Finance.
The company also announced that Linda L. Chang has joined the Company as Senior Vice President, Chief Financial Officer, effective November 7, 2011. Ms. Chang is responsible for Accounting, Finance, Information Technology, and Investor Relations functions at PharmAthene.
Prior to joining PharmAthene, Ms. Chang spent 11 years at Human Genome Sciences, Inc., (Nasdaq: HGSI) most recently as Senior Director of Finance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
Earnings, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
